TABLE 3.
Patient no. | Agglutination titer
|
Anti-M. pneumoniae IgG (RU)
|
||
---|---|---|---|---|
Acute phase | Convalescent phase | Acute phase | Convalescent phase | |
1 | 160 | >640a | 5 | 115a |
2 | 40 | 160a | 144 | 388 |
3 | 2,560 | 2,560 | 32 | 578a |
4 | 80 | 40 | 17 | 15 |
5 | 160 | 160 | 692 | 197 |
6 | 320 | 640 | 274 | 926 |
7 | 160 | 1,280a | 10 | 1,106a |
8 | <40 | 320a | 172 | >2,560a |
9 | <40 | >640a | 10 | 287a |
10 | 80 | >640a | 291 | >2,560a |
11 | 40 | 160a | 121 | >2,560a |
12 | 40 | 640a | 70 | >2,560 |
13 | 80 | >640a | 9 | 57a |
14 | <40 | 80 | 113 | 126 |
15 | <40 | >640a | 14 | 413a |
16 | <40 | 160a | 54 | 7,679a |
17 | 160 | >640a | 13 | 1,125a |
18 | <40 | 80 | >2,560 | >2,560 |
19 | <40 | >640a | 12 | 9,903a |
20 | 80 | >640a | 150 | >2,560a |
21 | 80 | 160 | 155 | 286 |
22 | <40 | <40 | 172 | 298 |
23 | <40 | <40 | 395 | 306 |
24 | <40 | <40 | 274 | 1,166a |
25 | <40 | <40 | 174 | 308 |
26 | <40 | <40 | 93 | 136 |
27 | <40 | <40 | 142 | 185 |
28 | <40 | <40 | 30 | 31 |
29 | <40 | <40 | 293 | 219 |
30 | <40 | <40 | 66 | 73 |
Fourfold or greater change in RU or agglutination titer.